NEW PRODUCTS NOW AVAILABLE-Nov 2021

https://www.businesswire.com/news/home/20211115005109/en/Bayshore-Pharmaceuticals-Announces-Commercial-Launch-of-ANDA-Approved-Products

Metolazone Tablets

• Metolazone 2.5MG Tablet 100 Count (76385-0136-01)
• Metolazone 5MG Tablet 100 Count (76385-0137-01)
• Metolazone 10MG Tablet 100 Count (76385-0138-01)

Etodolac IR Tablets

• Etodolac IR 400MG Tablet 100 Count (76385-0118-01)
• Etodolac IR 500MG Tablet 100 Count (76385-0119-01)

Ketotifen Fumarate Ophthalmic Drops

• KETOTIFEN FUMARATE 0.035% 5ml (76385-0106-17)